Utilize Guardant’s portfolio of liquid biopsy tests in Pfizer’s global clinical studies. Evaluate the clinical utility of (a) circulating tumor DNA (ctDNA) level as a surrogate endpoint to monitor ...
Streamlined access to Guardant Shield ™ will help millions of people residing in senior living facilities to stay up to date on colorectal cancer screening LabFlorida/SunDX will provide patients in ...
Health officials introduce blood test as a more pleasant option to encourage greater participation in screening and boost early detection of colorectal cancer PALO ALTO, Calif.--(BUSINESS ...
InvestorsHub on MSN
Guardant Health Shares Climb on FDA Breakthrough Status for Cancer Detection Test
Guardant Health Inc. (NASDAQ:GH) saw its stock rise by 3.7% after announcing that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its Shield multi-cancer ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it has entered into an agreement with Bayshore HealthCare, a leading home ...
Health officials introduce blood test as a more pleasant option to encourage greater participation in screening and boost early detection of colorectal cancer Colorectal cancer is the third most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results